Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3299022013 | Parenteral form amphotericin B liposome | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3299253016 | Parenteral form amphotericin B liposome (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488681014 | Product containing amphotericin B liposome in parenteral dosage form (medicinal product form) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 3497847017 | Amphotericin B liposome in parenteral dosage form | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3497848010 | Product containing amphotericin B liposome in parenteral dosage form | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing amphotericin B liposome in parenteral dosage form | Is a | Product containing amphotericin B liposome | false | Inferred relationship | Existential restriction modifier | ||
| Product containing amphotericin B liposome in parenteral dosage form | Is a | Product containing amphotericin B in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing amphotericin B liposome in parenteral dosage form | Has active ingredient | Amphotericin B liposome | false | Inferred relationship | Existential restriction modifier | ||
| Product containing amphotericin B liposome in parenteral dosage form | Has manufactured dose form | Parenteral dose form | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial | Is a | False | Product containing amphotericin B liposome in parenteral dosage form | Inferred relationship | Existential restriction modifier | |
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 10mL vial | Is a | False | Product containing amphotericin B liposome in parenteral dosage form | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets